TNF and myositis disease: The inhibition of TNF-α has been proposed as a promising therapeutic approach in experimental studies and animal models of myositis, which showed increased TNF-α expression in affected muscles and reduction of inflammation by experimental treatment with TNF-α blockers [56–58]; however, the current clinical evidence on anti-TNF-α treatment in myositis is variable.